American Healthcare REIT, Inc. (NYSE:AHR – Get Free Report) EVP Mark Foster sold 1,500 shares of the firm’s stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $49.35, for a total value of $74,025.00. Following the completion of the transaction, the executive vice president owned 57,600 shares in the company, valued at $2,842,560. This represents a 2.54% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
American Healthcare REIT Stock Down 2.8%
American Healthcare REIT stock traded down $1.36 during trading on Wednesday, hitting $47.81. 1,967,891 shares of the company were exchanged, compared to its average volume of 1,606,943. The company has a market capitalization of $8.06 billion, a P/E ratio of 341.51, a PEG ratio of 2.43 and a beta of 0.98. The business’s 50 day moving average is $43.24 and its 200 day moving average is $39.16. American Healthcare REIT, Inc. has a 52 week low of $26.11 and a 52 week high of $50.51. The company has a current ratio of 0.44, a quick ratio of 0.48 and a debt-to-equity ratio of 0.37.
American Healthcare REIT Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, October 17th. Stockholders of record on Tuesday, September 30th were issued a $0.25 dividend. The ex-dividend date was Tuesday, September 30th. This represents a $1.00 annualized dividend and a dividend yield of 2.1%. American Healthcare REIT’s dividend payout ratio is currently 714.29%.
Institutional Trading of American Healthcare REIT
Analyst Upgrades and Downgrades
A number of research firms recently weighed in on AHR. Baird R W raised shares of American Healthcare REIT to a “strong-buy” rating in a research report on Thursday, July 17th. Citigroup reissued an “outperform” rating on shares of American Healthcare REIT in a research report on Friday, October 17th. UBS Group assumed coverage on American Healthcare REIT in a research report on Friday, September 19th. They set a “buy” rating and a $51.00 price target for the company. Royal Bank Of Canada lifted their price target on American Healthcare REIT from $45.00 to $54.00 and gave the stock an “outperform” rating in a report on Wednesday. Finally, Scotiabank restated an “outperform” rating on shares of American Healthcare REIT in a research note on Thursday, August 28th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $47.40.
Read Our Latest Analysis on American Healthcare REIT
American Healthcare REIT Company Profile
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Further Reading
- Five stocks we like better than American Healthcare REIT
- How to find penny stocks to invest and trade
- Rare Earth Stocks: The Truce That Isn’t a Truce
- What is a Dividend King?
- Carving Up Profits: 3 Food Stocks on the Thanksgiving Table
- Expert Stock Trading Psychology Tips
- C3.ai’s Reset: Why New Leadership Could Spark a Turnaround
Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
